Outcome of pregnancies after onset of the neuromyelitis optica spectrum disorder
- 22 April 2020
- journal article
- research article
- Published by Wiley in European Journal of Neurology
- Vol. 27 (8), 1546-1555
- https://doi.org/10.1111/ene.14274
Abstract
Background Data on pregnancy outcome of neuromyelitis optica spectrum disorder (NMOSD) remain limited, especially for woman who had received immunosuppressive treatment before becoming pregnant. We aimed to evaluate the outcome of pregnancy among patients with NMOSD who attempted to become pregnant after NMOSD onset and to identify risk factors that predict pregnancy‐related attack. Methods We retrospectively evaluated medical records from 29 patients who attempted to become pregnant after NMOSD onset and interviewed them for pregnancy outcomes. Pregnancy‐related attack was defined as an attack that occurred during pregnancy or within 1 year of delivery. Results Among the 29 patients, 26 had 33 pregnancies after NMOSD symptom onset. The 33 pregnancies after NMOSD onset resulted in 24 live births (healthy neonates except one with low birth weight), 6 miscarriages, and 3 elective abortions. Pregnancy‐related attack occurred in nine (75%) of 12 pregnancies before initiation of immunosuppressive therapy, but in only five (24%) of 21 pregnancies after initiation of immunosuppressive therapy (p=0.009). Multivariable analysis indicated that pregnancy‐related attack was negatively associated with pregnancy after initiation of rituximab (odds ratio 0.048; 95% confidence interval 0.004‐0.546). Conclusions Successful pregnancy without maternal and neonatal complications may be feasible in patients with NMOSD. Rituximab treatment before pregnancy might help to prevent pregnancy‐related attack in patients with NMOSD.Keywords
This publication has 38 references indexed in Scilit:
- Racial differences in neuromyelitis optica spectrum disorderNeurology, 2018
- High risk of postpartum relapses in neuromyelitis optica spectrum disorderNeurology, 2017
- Effectiveness and safety of immunosuppressive therapy in neuromyelitis optica spectrum disorder during pregnancyJournal of the Neurological Sciences, 2017
- Pregnancy in neuromyelitis optica spectrum disorder: A multicenter study from South ChinaJournal of the Neurological Sciences, 2016
- Pregnancy-related relapse risk factors in women with anti-AQP4 antibody positivity and neuromyelitis optica spectrum disorderMultiple Sclerosis Journal, 2016
- Pregnancy outcomes in aquaporin-4–positive neuromyelitis optica spectrum disorderNeurology, 2016
- International consensus diagnostic criteria for neuromyelitis optica spectrum disordersNeurology, 2015
- Neuromyelitis optica and pregnancyZeitschrift für Neurologie, 2013
- Influence of pregnancy on neuromyelitis optica spectrum disorderNeurology, 2012
- Neuromyelitis optica and pregnancyNeurology, 2012